Home » Topics » Regulatory » Patents

Patents
RSS

Monoclonal antibody fragments as immunosuppressants

July 26, 1996

COX-2 inhibitors described to treat inflammation

July 26, 1996

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Carbapenem derivatives with antibacterial activity claimed by Yamanouchi

July 26, 1996

Human Genome Sciences claims VIGF polypeptide technology

July 26, 1996

Ulinastatin claimed by Mochida as skin disorder treatment

July 26, 1996

Chugai describes 24-oxo-22-oxavitamin D3 derivatives

July 26, 1996

RPR describes tachykinin NK1 antagonists

July 26, 1996

Pharmacia & Upjohn reveals non-enzymatic protein glycosylation inhibitors

July 19, 1996

Janssen describes agent for decreased intestinal motility

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...